GE HealthCare Files 8-K: Other Events & Exhibits

Ticker: GEHC · Form: 8-K · Filed: 2024-08-09T00:00:00.000Z

Sentiment: neutral

Topics: 8-K, filing, regulatory

TL;DR

GE HealthCare filed an 8-K for 'Other Events' - check the full doc for impact.

AI Summary

GE HealthCare Technologies Inc. filed an 8-K on August 9, 2024, reporting an event that occurred on August 7, 2024. The filing pertains to 'Other Events' and 'Financial Statements and Exhibits'. No specific financial figures or new material events were detailed in the provided excerpt.

Why It Matters

This 8-K filing indicates GE HealthCare Technologies Inc. is reporting on events or submitting exhibits as required by the SEC. Investors should review the full filing for details on any significant developments.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for reporting events and exhibits, with no immediate indication of negative financial impact or significant operational changes in the provided text.

Key Players & Entities

FAQ

What specific 'Other Events' are being reported by GE HealthCare Technologies Inc. in this 8-K filing?

The provided excerpt does not specify the details of the 'Other Events'; it only indicates that this item is being reported.

What is the significance of the 'Financial Statements and Exhibits' being listed as an item in this 8-K?

This indicates that the filing includes financial statements or exhibits, which are typically supplementary documents or required disclosures.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on August 7, 2024.

What is the Commission File Number for GE HealthCare Technologies Inc.?

The Commission File Number for GE HealthCare Technologies Inc. is 001-41528.

Where are GE HealthCare Technologies Inc.'s principal executive offices located?

GE HealthCare Technologies Inc.'s principal executive offices are located at 500 W. Monroe Street, Chicago, IL 60661.

From the Filing

0001193125-24-197921.txt : 20240809 0001193125-24-197921.hdr.sgml : 20240809 20240809165400 ACCESSION NUMBER: 0001193125-24-197921 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240807 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240809 DATE AS OF CHANGE: 20240809 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GE HealthCare Technologies Inc. CENTRAL INDEX KEY: 0001932393 STANDARD INDUSTRIAL CLASSIFICATION: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 882515116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41528 FILM NUMBER: 241193704 BUSINESS ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 BUSINESS PHONE: 833-735-1139 MAIL ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 FORMER COMPANY: FORMER CONFORMED NAME: GE Healthcare Holding LLC DATE OF NAME CHANGE: 20220603 8-K 1 d731205d8k.htm 8-K 8-K false 0001932393 0001932393 2024-08-07 2024-08-07     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 7, 2024     GE HEALTHCARE TECHNOLOGIES INC. (Exact name of registrant as specified in its charter)       Delaware   001-41528   88-2515116 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)   500 W. Monroe Street , Chicago , IL       60661 (Address of principal executive offices)     (Zip Code) (Registrant’s telephone number, including area code) (833) 735-1139 (Former name or former address, if changed since last report.)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common stock, par value $0.01 per share   GEHC   The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. ☐       Item 8.01. Other Events. On August 7, 2024, GE HealthCare Technologies Inc. (the “Company”) commenced and priced an underwritten offering (the “Offering”) of $1,000,000,000 aggregate principal amount of 4.800% Notes due August 14, 2029 (the “Notes”) pursuant to the registration statement on Form S-3 (File No. 333-280584), filed with the Securities and Exchange Commission on June 28, 2024. The Notes are expected to be issued on or around

View on Read The Filing